Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2021 当医生发现其患者被强制绝育时应如何应对? Rebecca Kluchin(理学博士) AMA J Ethics. 2021;E18-25. doi: 10.1001/amajethics.2021.18. Case and Commentary Feb 2021 通过避免判断主义和情境化护理来促进卫生公平性 Saul J. Weiner (医学博士) AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91. Case and Commentary Feb 2021 Fomento de la equidad en salud a través de un enfoque que evite los juicios de valor y contextualice la atención Saul J. Weiner, MD AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91. State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015;17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511. Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117. Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010. Policy Forum Dec 2020 Inconsistency in Brain Death Determination Should Not Be Tolerated Erin Barnes, MD and David Greer, MD, MA Since 1995, the American Academy of Neurology has provided guidelines for brain death determination, but nationwide adherence to these guidelines has been incomplete. AMA J Ethics. 2020;22(12):E1027-1032. doi: 10.1001/amajethics.2020.1027. Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020;22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033. Policy Forum Dec 2020 What Should We Do About the Mismatch Between Legal Criteria for Death and How Brain Death Is Diagnosed? Nathaniel M. Robbins, MD and James L. Bernat, MD Criteria in statutes and tests used to diagnose brain death don’t always jibe, and this can undermine public trust in death pronouncements. AMA J Ethics. 2020;22(12):E1038-1046. doi: 10.1001/amajethics.2020.1038. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Jan 2021 当医生发现其患者被强制绝育时应如何应对? Rebecca Kluchin(理学博士) AMA J Ethics. 2021;E18-25. doi: 10.1001/amajethics.2021.18.
Case and Commentary Feb 2021 通过避免判断主义和情境化护理来促进卫生公平性 Saul J. Weiner (医学博士) AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91.
Case and Commentary Feb 2021 Fomento de la equidad en salud a través de un enfoque que evite los juicios de valor y contextualice la atención Saul J. Weiner, MD AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91.
State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015;17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511.
Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117.
Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010.
Policy Forum Dec 2020 Inconsistency in Brain Death Determination Should Not Be Tolerated Erin Barnes, MD and David Greer, MD, MA Since 1995, the American Academy of Neurology has provided guidelines for brain death determination, but nationwide adherence to these guidelines has been incomplete. AMA J Ethics. 2020;22(12):E1027-1032. doi: 10.1001/amajethics.2020.1027.
Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020;22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033.
Policy Forum Dec 2020 What Should We Do About the Mismatch Between Legal Criteria for Death and How Brain Death Is Diagnosed? Nathaniel M. Robbins, MD and James L. Bernat, MD Criteria in statutes and tests used to diagnose brain death don’t always jibe, and this can undermine public trust in death pronouncements. AMA J Ethics. 2020;22(12):E1038-1046. doi: 10.1001/amajethics.2020.1038.